STAAR Surgical Company Gross Profit 2011-2026 | STAA

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:

Raw materials and supplies

Wages of production personnel

Depreciation of equipment

Transportation and warehousing costs (if directly related to production)

Importance for business:

Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales.
Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit.
Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry.
Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.

Reasons for a decline in gross profit:

Increase in raw material and supply costs
Rising production expenses
Price reductions due to competition
Decrease in sales volume
Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit STAAR Surgical Company

2026	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
182 M	240 M	253 M	223 M	179 M	112 M	-	91.5 M	64.3 M	52.7 M	48.8 M	50.3 M	-	44.3 M	42.4 M	35.1 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
253 M	35.1 M	116 M

Quarterly Gross Profit STAAR Surgical Company

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
68.9 M	77.9 M	32.8 M	28 M	-	68.5 M	78.4 M	61 M	-	63.6 M	70.7 M	57.6 M	-	60.5 M	63.9 M	49.3 M	45 M	45.3 M	49.2 M	39.1 M	28.8 M	34.9 M	24.4 M	24.8 M	-	29.1 M	29.9 M	24.2 M	23 M	23.9 M	25.2 M	19.4 M	17.4 M	16.8 M	15.5 M	14.6 M	15.9 M	14.9 M	14.6 M	13 M	9.4 M	12.8 M	12.4 M	12.9 M	13 M	11.9 M	13.7 M	13.9 M	-	12.1 M	12.6 M	12.7 M	11.2 M	11.2 M	11 M	10.9 M	11.4 M	10.4 M	10.9 M	9.63 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
78.4 M	9.4 M	29 M

Gross Profit of other stocks in the Medical instruments industry

Issuer	Gross Profit	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	62.4 K	-	-	$ 810 M	USA
The Cooper Companies COO	2.68 B	$ 67.34	8.58 %	$ 13.4 B	USA
Glaukos Corporation GKOS	283 M	$ 125.0	2.72 %	$ 7.15 B	USA
Luminex Corporation LMNX	248 M	-	-	$ 1.75 B	USA
Akers Biosciences, Inc. AKER	479 K	-	-9.52 %	$ 20.6 M	USA
Intuitive Surgical ISRG	6.64 B	$ 422.06	0.77 %	$ 151 B	USA
Alcon ALC	5.74 B	$ 66.81	0.35 %	$ 40.4 B	Schweiz
ICU Medical ICUI	822 M	$ 136.61	1.25 %	$ 3.37 B	USA
iRhythm Technologies IRTC	527 M	$ 108.11	0.7 %	$ 3.46 B	USA
Repro Med Systems KRMD	25.6 M	$ 3.93	-5.07 %	$ 182 M	USA
LeMaitre Vascular LMAT	179 M	$ 94.48	0.98 %	$ 2.14 B	USA
Masimo Corporation MASI	1 B	$ 178.82	-0.04 %	$ 9.53 B	USA
Antares Pharma, Inc. ATRS	86.5 M	-	-	$ 955 M	USA
Cantel Medical Corp. CMD	436 M	-	-1.18 %	$ 3.4 B	USA
CRH Medical Corporation CRHM	1.68 M	-	-	$ 282 M	USA
Hill-Rom Holdings, Inc. HRC	1.48 B	-	-0.05 %	$ 10.3 B	USA
Microbot Medical MBOT	117 K	$ 1.84	-6.12 %	$ 84.3 M	Israel
Ekso Bionics Holdings EKSO	6.84 M	-	-	$ 28.6 M	USA
Milestone Scientific MLSS	6.41 M	$ 0.42	-4.31 %	$ 34.5 M	USA
Varian Medical Systems, Inc. VAR	1.38 B	-	-0.02 %	$ 16.3 B	USA
electroCore ECOR	27.8 M	$ 8.72	-12.27 %	$ 74 K	USA
Envista Holdings Corporation NVST	1.49 B	$ 23.1	1.03 %	$ 3.88 B	USA
Haemonetics Corporation HAE	788 M	$ 71.28	2.05 %	$ 3.36 B	USA
STERIS plc STE	2.63 B	$ 212.35	0.05 %	$ 20.9 B	USA
Isoray ISR	1.43 M	-	0.03 %	$ 108 M	USA
InfuSystem Holdings INFU	80.3 M	$ 9.24	1.32 %	$ 191 M	USA
Teleflex Incorporated TFX	307 M	$ 129.84	-1.72 %	$ 5.79 B	USA
Utah Medical Products UTMD	5.26 M	$ 67.65	-0.5 %	$ 219 M	USA
Merit Medical Systems MMSI	738 M	$ 64.48	2.28 %	$ 3.81 B	USA
West Pharmaceutical Services WST	1.1 B	$ 314.5	-0.89 %	$ 22.7 B	USA
DENTSPLY SIRONA XRAY	1.84 B	$ 10.0	1.21 %	$ 1.99 B	USA
Retractable Technologies RVP	47 K	$ 0.69	3.96 %	$ 20.7 M	USA
Pro-Dex PDEX	19.5 M	$ 65.21	-2.67 %	$ 214 M	USA
Predictive Oncology POAI	6.53 K	-	-	$ 31.1 M	USA
BioLife Solutions BLFS	62.1 M	$ 26.64	-1.66 %	$ 1.27 B	USA
Stereotaxis STXS	17.1 M	$ 1.78	-5.07 %	$ 162 M	USA
Baxter International BAX	3.38 B	$ 19.38	0.16 %	$ 9.94 B	USA
ResMed RMD	2.02 B	$ 196.04	0.89 %	$ 28.6 B	USA
AtriCure ATRC	401 M	$ 27.1	-0.62 %	$ 1.29 B	USA
Harvard Bioscience HBIO	49.9 M	$ 6.2	-4.4 %	$ 275 M	USA
NeuroMetrix NURO	1.68 M	-	5.05 %	$ 9.02 M	USA
AngioDynamics ANGO	158 M	$ 11.94	-0.75 %	$ 488 M	USA
Becton, Dickinson and Company BDX	8.29 B	$ 151.16	1.12 %	$ 43.5 B	USA
Nephros NEPH	11.6 M	$ 3.42	-4.74 %	$ 36.3 M	USA
OraSure Technologies OSUR	48.2 M	$ 4.04	-3.12 %	$ 297 M	USA
Repligen Corporation RGEN	151 M	$ 122.31	-3.35 %	$ 6.88 M	USA